Product NDC: | 0054-0436 |
Proprietary Name: | Dipyridamole |
Non Proprietary Name: | Dipyridamole |
Active Ingredient(s): | 75 mg/1 & nbsp; Dipyridamole |
Administration Route(s): | ORAL |
Dosage Form(s): | TABLET |
Coding System: | National Drug Codes(NDC) |
Product NDC: | 0054-0436 |
Labeler Name: | Roxane Laboratories, Inc. |
Product Type: | HUMAN PRESCRIPTION DRUG |
FDA Application Number: | NDA012836 |
Marketing Category: | NDA AUTHORIZED GENERIC |
Start Marketing Date: | 20120215 |
Package NDC: | 0054-0436-25 |
Package Description: | 100 TABLET in 1 BOTTLE (0054-0436-25) |
NDC Code | 0054-0436-25 |
Proprietary Name | Dipyridamole |
Package Description | 100 TABLET in 1 BOTTLE (0054-0436-25) |
Product NDC | 0054-0436 |
Product Type Name | HUMAN PRESCRIPTION DRUG |
Non Proprietary Name | Dipyridamole |
Dosage Form Name | TABLET |
Route Name | ORAL |
Start Marketing Date | 20120215 |
Marketing Category Name | NDA AUTHORIZED GENERIC |
Labeler Name | Roxane Laboratories, Inc. |
Substance Name | DIPYRIDAMOLE |
Strength Number | 75 |
Strength Unit | mg/1 |
Pharmaceutical Classes | Decreased Platelet Aggregation [PE],Platelet Aggregation Inhibitor [EPC] |